Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ugur Sahin currently holds 36,209 shares of BioNTech SE (BNTX), valued at approximately $0. This represents their equity stake as Chief Executive Officer.
Based on SEC Form 4 filings, Ugur Sahin has been a net seller of BNTX stock. They have purchased $0 and sold $42.6M worth of shares.
Ugur Sahin's most recent insider trade was on Oct 9, 2026, when they sold 36,209 shares at $95.37 per share.
Ugur Sahin serves as Chief Executive Officer at BioNTech SE (BNTX). They have executed 14 insider transactions totaling $42.6M over their tenure at the company.
Ugur Sahin holds the position of Chief Executive Officer at BioNTech SE, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Ugur Sahin has shown a selling trading pattern, with $0 in total purchases and $42.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ugur Sahin was on Oct 5, 2026, when they sold $7.0M worth of BNTX shares. This transaction involved 72,000 shares at $97.23 per share.
Ugur Sahin currently owns 36,209 shares of BioNTech SE (BNTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ugur Sahin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ugur Sahin has 14 Form 4 filings on record as an insider at BioNTech SE.
Set alerts for Ugur Sahin and 40,000+ other insiders.